Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets.

Bio-Techne Corporation (NASDAQ ... However, this brings up another question – is now the right time to sell? If you believe TECH should trade below its current price, selling high and buying ...

Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, ...

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that BrainChild Bio has been awarded a $300,000 G-Rex® Grant. The G-Rex® Grant will ...

Bio-Techne (TECH) prevailed on another claim that Miltenyi Biotec KG commercialized antibodies developed based on information obtained by ...

Bio-Techne Corporation ( NASDAQ:TECH ) saw a double-digit share price rise of over 10% in the past couple of months ...

We’re sorry, we are currently experiencing some issues, please try again later. Our team is working diligently to resolve the issue. Thank you for your patience and ...

Wilson Wolf's mission is to create hope for cancer patients, one G-Rex® device at a time. About Bio-Techne Corporation Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company ...

EXEL is near its 52-week high but remains below its all-time high reached in 2017 ... between 20 and 30 over the last three years. Bio-Techne develops instruments and reagents used in medical ...

In executive moves, Bio-Techne granted its Executive Vice President and Chief Financial Officer, James Hippel, a one-time award of 34,634 restricted stock units (RSUs) as a retention incentive. Baird, ...

This was the stock's second consecutive day of losses.